Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticles

Acta Biomaterialia(2020)10.1016/j.actbio.2020.11.018Source: DataRank Database

Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticles is a research paper published in Acta Biomaterialia (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 1.22)OA: greenTopics (46)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Naroa Serna ORCID,Laura Sánchez‐García ORCID,Anna Aviñó ORCID,Julieta M. Sánchez ORCID,Hèctor López‐Laguna ORCID

Live enrichment

PubMed:33189955 OpenAlex:https://openalex.org/W3101982115

Agència de Gestió d'Ajuts Universitaris i de Recerca

Grant: 2018FI_B2_00051

Agència de Gestió d'Ajuts Universitaris i de Recerca

Grant: 1027SGR-865

Agència de Gestió d'Ajuts Universitaris i de Recerca

Grant: 2017SGR-229

Agència de Gestió d'Ajuts Universitaris i de Recerca

Grant: 2019FI_B00352

Instituto de Salud Carlos III

Grant: CP19/00028

Instituto de Salud Carlos III

Grant: PI18/00650

National Institutes of Health

Grant: P41-GM103311

European Regional Development Fund

Grant: BIO2016-76063-R

European Regional Development Fund

Grant: PID2019-105416RB-I00

FWCI

1.22

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2026

greenLicense: cc-by-nc-sa

repositoryhttp://hdl.handle.net/11336/125077

publisherhttps://api.elsevier.com/content/article/PII:S1742706120306619?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1742706120306619?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.actbio.2020.11.018

Fields of Study

Toxin Mechanisms and ImmunotoxinsBacteriophages and microbial interactionsImmunotherapy and Immune ResponsesAntineoplastic AgentsHumansNanoconjugatesNanoparticlesNeoplasmsProteinsPseudomonas aeruginosa

MeSH Terms

Antineoplastic AgentsHumansNeoplasmsProteinsPseudomonas aeruginosaNanoparticlesNanoconjugates

Keywords

Pseudomonas exotoxinCytotoxic T cellConjugateCorynebacterium diphtheriaeDiphtheria toxinNanotechnologyMaterials scienceDrug deliveryDrugNanoparticleDrug resistanceTargeted drug deliveryCancer researchPharmacologyCombinatorial chemistryChemistryCytotoxicityToxinMicrobiologyMedicineBiologyBiochemistryImmunologyDiphtheriaIn vitroRecombinant proteinsdrug combinationhybrid materialsnanoparticles

Sustainable Development Goals

SDG 0: Good health and well-being